Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/17/2010

an overall survival benefit.  The study will enroll about 800 patients worldwide.  

While we already showed a 33% improvement in overall survival in Phase II, we only need 10% in the Phase III study to meet our primary endpoint. We have added multiple years to the development process of Multikine in order to build a Multikine dedicated manufacturing facility near Baltimore.  This was done at the advice of the regulatory agencies and as an additional step of risk mitigation since the use of a contract manufacturer adds a great deal of risk in maintaining quality control.  We have taken every conceivable risk mitigation step to increase the probability of a favorable outcome for this breakthrough product.

On the other hand, recognizing that every drug development carries risk, we have attempted to set the study up to become a huge financial success for the shareholders.  Assuming we are right, Multikine will become the first treatment to be used in the treatment of nearly all newly diagnosed head and neck cancer patients (about 650,000 patients worldwide).  It will become part of the new standard of care.  That means that doctors will be advised to use Multikine as the first treatment for head and neck cancer patients.  Insurance companies and governments should reimburse the use of Multikine because it will be cost effective and because they pay for the current standard of care treatments, surgery, radiation and chemotherapy.  This would translate into billions of dollars in sales while at the same time helping to save lives.  Usually such successes are shared with a big pharmaceutical partner and the upside for the small company's shareholders is limited.  In the case of CEL-SCI, shareholders still control most of the upside as CEL-SCI still owns all of the major marketing rights.  Very few companies find themselves in this advantageous position a
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
6. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI Corporation Announces 2007 Financial Results
9. CEL-SCI Corporation Reports First Quarter Financial Results
10. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
11. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... , , , ... announced the start of a phase II human clinical trial of ... people with diabetes mellitus. The randomized, controlled 12-week trial in patients ... Clinic in Rochester, Minn., and McGill University Health Centre in Montreal, ...
... Potential to Treat a Broad Spectrum of Migraine,***UPDATED SATELLITE ... common, debilitating neurological disorder that affects,approximately 30 million people ... Limitations of oral triptans, the class of,prescription drugs widely ... between 45 and 90 minutes, substantial variability in,patient response ...
Cached Medicine Technology:Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes 2MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS 2
(Date:4/17/2014)... identified the first genetic variant specifically associated with ... for around 10-15 per cent of all breast ... the breast cancer sub-type, called invasive lobular carcinoma, ... of this particular kind of breast cancer, which ... published today (Thursday) in the journal PloS ...
(Date:4/17/2014)... the April issue of Experimental Biology and ... Drs. Rex Gaskins and Paul Kenis in the ... of the University of Illinois Urbana-Champaign describe their ... reactions underlie a variety of cell functions including ... these crucial roles in regulating normal cellular behavior, ...
(Date:4/17/2014)... Le Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, ... the April issue of Nature Reviews Microbiology ... Dr. McCullers, a world-renowned infectious disease specialist, ... the University of Tennessee Health Science Center, analyzed ... 1918, 1957 and 1968 pandemics, as well as ...
(Date:4/17/2014)... older Americans suffer from depression, often brought on by ... a project that followed the lives of thousands ... that Internet use among the elderly can reduce the ... "That,s a very strong effect," said Shelia Cotten, a ... media who led the project. "And it all has ...
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... ... up the running shoes and get moving. While many older people tend to slow down in ... say that keeping active all year is the key to good health, particulary for senior citizens. ... (Vocus) March 9, 2010 -- With ...
... hospitalist at the University of Rochester Medical Center calls ... potential new drugs, in a commentary in the March ... Medical Association . Alec B. O,Connor, M.D., M.P.H., ... Department of Medicine, says that while the U.S. Food ...
... ... ... , ... , , ...
... , ... ... ... ...
... recommendations from a national workshop have been released to ... growing public health problem estimated to affect nearly 1 ... a diverse group of representatives from federal health agencies ... medical and public health communities appear in the ...
... oophorectomy) while performing a hysterectomy is common practice to ... procedure is performed in 55 percent of all US ... year. An article in the March/April issue of t ... ovaries (bilateral oophorectomy) while performing a hysterectomy is common ...
Cached Medicine News:Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 2Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 3Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 4Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 5Health News:Physician calls for more rigorous standards for drugs up for FDA approval 2Health News:Physician calls for more rigorous standards for drugs up for FDA approval 3Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 2Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 3Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 4Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 5Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 2Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 3Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 4Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 5Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 6Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 7Health News:Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism 2Health News:Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism 3Health News:New study questions benefits of elective removal of ovaries during hysterectomy 2
PDA formatted guide containing outlines and detailed information on the diagnosis and treatment of HIV infection and AIDS....
PDA version of the best-selling guide....
PDA application contains 15,000+ ICD-9-CM Diagnosis codes....
More than 200 key diagnostic and treatment tables culled from Tierney's Current Medical Diagnostics and Treatment 2003....
Medicine Products: